Feb Vertex Update - Kalydeco receives FDA approval for 8 gating mutations
I've just summarised the Feb 25 Vertex investor conference, includes info about Kalydeco, VX809, VX661 and second generation correctors:
http://sixtyfiverosesblog.wordpress....vertex-update/
Also, last week it was announced that Kalydeco received FDA approval for eight gating mutations: G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D.
http://investors.vrtx.com/releasedet...leaseID=827435
Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - Category: Respiratory Medicine Authors: GenH Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums